Generic Allegra Only 120mg x 90 pills $99.55
Lowest price on medication. Discreet Packing Fast Worldwide Delivery.
www.all-tablet.com
Cheap Generic Allegra Only 120mg x 120 pills $130.10 US
Best Drugstore. No rx prescription needed. Privacy!
www.tadalafiltrusted.com
Cataracts are an eye condition characterized by a cloudiness of the eye’s lens. They usually develop slowly as a person gets older.
The U.S. National Library of Medicine offers this list of cataract symptoms:
Vision that appears foggy or cloudy; as if there’s a film over the eye.
Inability to see colors as vividly as before.
Seeing double.
Problems seeing well at night.
Seeing an aura or halo surrounding lights.
Increased sensitivity to glaring lights.
Difficulty in differentiating shapes or similar colors.
Nearly 200 million children in developing countries suffer from stunted growth and health problems due to poor nutrition in their early years, the U.N. children’s foundation UNICEF said on Wednesday.
However, the percentage of children with retarded growth in Asia fell to 30 percent last year from 44 percent in 1990, and in Africa to 34 percent from 38 percent over the same period, UNICEF said in a report.
Despite a decline in the rate of the problem, 195 million children in developing countries under 5 years old have stunted growth due to poor nutrition during the critical period between their conception and second birthdays, UNICEF said.
Undernourished children often have poor physical health and slower mental development. When the problem is widespread, as in India and Afghanistan, it undermines those countries’ ability to improve their economies and eradicate poverty.
“Undernutrition steals a child’s strength and makes illnesses that the body might otherwise fight off far more dangerous,” UNICEF Executive Director Ann Veneman said in a statement.
“More than one third of children who die from pneumonia, diarrhea and other illnesses could have survived had they not been undernourished,” she said.
More than 90 percent of the developing world’s children facing stunted growth live in Africa and Asia, the report said. A third of them — roughly 60.8 million — are in India.
UNICEF said that countries with the highest prevalence of stunted growth among children under the age of five include Afghanistan (59 percent), Yemen (58 percent), Guatemala and East Timor (both 54 percent), Democratic Republic of the Congo (46 percent) and North Korea (45 percent).
India, the world’s second most-populous country, continues to have a high rate of children under 5 years old suffering from retarded growth, though it fell from around 52 percent in 1992-1993 to 43 percent in 2005-2006, UNICEF said.
Veneman told reporters on a conference call that roughly 8.8 million children are dying every year from largely preventable causes and poor nutrition is a contributing factor in more than a third of those deaths.
She added that the issue of access to proper nutrition for impoverished children and pregnant and breastfeeding mothers was related to the larger issue of poor food security in a world where some 1 billion people are hungry or malnourished.
The 1,000 days from conception until a child’s second birthday are the most important for growth and development, the report said. Insufficient nutrition during this period can permanently harm the body’s ability to ward off and overcome diseases and damage a child’s social and mental development.
Stunted growth, UNICEF said, can rarely be corrected. However, Veneman said it can be prevented and programs to improve access to iodized salt and vitamin A supplements in Africa and Asia have improved the situation in some countries — and led to a reduction in infant and child mortality.
Sharing prescription medication with a family member or friend who needs care may seem like the right thing to do, even an act of kindness. But new research highlights the potential hazards of passing these medicines around.
Of people who borrowed a medicine prescribed for someone else, 25.1 percent experienced some sort of side effect, researchers reported Wednesday at the American Public Health Association annual meeting in Philadelphia.
While 77.3 percent of prescription borrowers said they had bummed medicine rather than see a health-care provider, for many it merely delayed the inevitable. That’s because one in three ended up seeking medical care, anyway.
A lot of people have focused on “recreational medication sharing,” or abuse of prescription drugs “for a buzz,” explained lead investigator Richard C. Goldsworthy, director of research and development at The Academic Edge, a Bloomington, Ind.-based developer of educational media.
“What people haven’t looked at is what we started to call ‘altruistic medication sharing,’” he said. “It’s ‘You’re not feeling so well,’ and a friend happens to have some extra medicine of a certain kind that treats symptoms similar to what you’re having, and they let you borrow it.”
In an earlier study, Goldsworthy and colleagues reported that 20 percent of U.S. teens say they swap prescription drugs such as antibiotics and allergy medicines with friends. The new study corroborates the frequency of drug-sharing in America, with one in five admitting to borrowing drugs.
Many people just think it’s “no big deal,” he explained.
Yet depending on the drug, the dosage and other factors, it can be a very big deal, one expert cautioned.
“There’s always been an issue, especially with medications such as pain medications,” said Allen J. Vaida, executive vice president at the Institute for Safe Medication Practices (ISMP), in Horsham, Pa.
Painkillers come in different dosages and some combine, say, an opioid with acetaminophen (the active ingredient in Tylenol), he said. If the borrower is already taking an over-the-counter pain reliever, such as Tylenol, he or she could be doubling the dose of acetaminophen, Vaida said.
In one tragic case, a 6-year-old with neck pain was found unconscious in bed the day after her foster mother placed a leftover fentanyl patch on the girl’s neck, ISMP reported. The child died before reaching the emergency room.
But pain medications are not the sole cause of unintentional consequences. Sharing eye-drops can result in the spread of infection, Vaida noted. Doling out leftover antibiotics can result in unnecessary treatment or treatment with the wrong antibiotic, he said. And taking someone else’s anti-anxiety medicine without the proper warnings can cause unanticipated dizziness or sleepiness behind the wheel of a car.
A week ago, the U.S. Food and Drug Administration (FDA) launched a new campaign aimed at reducing “preventable harm” from medication use. Taking medication meant for other people is among the potential dangers it highlighted.
“Too many people suffer unnecessary injuries from avoidable medication misuse, errors, and other problems,” FDA Commissioner Dr. Margaret A. Hamburg said in a statement. FDA is launching the Safe Use Initiative to develop targeted solutions for reducing these injuries.
To find out whether drug sharing is putting people in harm’s way, Goldsworthy had trained field agents conduct one-on-one interviews of almost 2,800 people in 11 different markets.
Of those who admitted to borrowing prescription medicines, many never got written (54.6 percent) or verbal (38.2 percent) warnings or instructions from the person loaning the medicine.
Among people who delayed seeking care, half of them never told their health-care provider that they had taken a borrowed medication.
“On the side effects, we don’t actually know the severity. It’s actually a limitation of the study,” Goldsworthy said. “And we also don’t know, in the analysis we’ve done so far, how many of those are actually people who sought a side effect.”
Still, the prevalence of side effects suggests that the risk for harm is a real possibility.
Avoiding unintended health consequences begins with education, Vaida said. Physicians, pharmacists and nurses need to tell patients not to share their medicines with family or friends, he explained.
People should also get in the habit of cleaning out their medicine cabinets and turning over leftover and unused drugs to community “take-back” programs, he added.
“That’s probably something that should be done all the time in every community,” Vaida said.
Taking nonsteroidal anti-inflammatory drugs (NSAIDs) from a young age might prevent early signs of Alzheimer’s disease, according to the results of a new study in mice.
Recent research suggests that the appearance of neuronal cell cycle events (CCEs) occurs early in the development of Alzheimer’s. In the new study, U.S. researchers looking for triggers of neuronal CCEs found evidence that suggests that neuroinflammation plays a role in the development of Alzheimer’s in mice.
Administration of the inflammatory molecule LPS triggered the early appearance of neuronal CCEs, the researchers found, and treatment with the NSAIDs ibuprofen or naproxen blocked the development of CCEs.
In older mice, treatment with NSAIDs prevented new neuronal CCEs but did not affect existing CCEs, the study authors noted.
The study, published online Nov. 9 in the Journal of Clinical Investigation, offers a potential explanation for findings in humans that long-term NSAID use protects against Alzheimer’s but does not benefit people who already have mild to moderate Alzheimer’s disease.
Micardis (telmisartan) has received expanded approval from the U.S. Food and Drug Administration to reduce the risk of heart attack or stroke in people 55 or older who cannot take a class of cardiovascular drugs called ACE inhibitors, maker Boehringer Ingelheim said Monday.
Micardis belongs to its own class called angiotensin II receptor blockers. It’s been available in the United States since 1998 to treat high blood pressure.
The FDA also granted new approval for a drug called Twynsta, which combines the active ingredient in Micardis with the calcium channel blocker amlodipine. The combination drug is meant to prevent high blood pressure when used alone, or in tandem with other anti-hypertension drugs, Boehringer said in a news release.
Some studies estimate that as many as 20 percent of people taking ACE inhibitors have side effects, which could prevent the drugs’ use as prescribed, the company said. Micardis has possible side effects of its own, including upper respiratory infection, back pain, sinusitis and diarrhea. The drug shouldn’t be used by pregnant women, Boehringer said.
Too few resident physicians have been trained in skin cancer examinations or watched or practiced the procedure, U.S. researchers report.
In a survey of 342 resident physicians in family medicine, obstetrics and gynecology, pediatrics and internal medicine, researchers collected information on the participants’ training and experience with skin cancer exams as well as their level of skill in performing the exams.
“Clinical training for the skin cancer examination during residency was infrequent,” wrote Dr. Emily Wise, of the Boston University School of Medicine, and colleagues. “During residency, 75.8 percent were never trained in the skin cancer examination, 55.3 percent never observed a skin cancer examination and 57.4 percent never practiced the examination. Only 15.9 percent of residents reported being skilled in the skin cancer examination.”
The researchers found that performing four skin cancer examinations (about one per year of residency) was associated with improvements in skill levels reported by the respondents.
The findings are published in the October issue of the Archives of Dermatology.
Melanoma is the second-most common cause of cancer in Americans aged 15 to 29. About one-quarter of melanomas are detected by doctors, rather than patients. Skin cancers discovered by doctors are generally thinner and have a better prognosis, according to background information in the study.
“Visits to internists and family practitioners make up an estimated 40 percent of physician visits in the United States, and nearly two-thirds of patients with melanoma report a physician visit in the year before diagnosis. Primary-care physicians are thus ideally suited to screen and triage high-risk patients and those with suspicious lesions,” the study authors wrote.
“Residency programs and medical schools may have neither the time nor the infrastructure to teach an expert, comprehensive examination to all physicians in training,” they concluded. “However, the basic ability to recognize potentially suspicious lesions and triage persons with such lesions should be a vital and key component of both training programs. If current physicians in training do not learn this skill set in medical school or residency, there is a low likelihood that they will acquire this knowledge in their day-to-day practice, which could have potentially devastating consequences for melanoma recognition going forward.”
Researchers say they’ve gained new understanding of how lupus develops in mice, a finding that could help future treatments for the autoimmune disease.
An estimated 1.5 million to 2 million people in the United States suffer from lupus, a disorder in which the body’s defenses turn inward. The condition can cause symptoms similar to those of arthritis and rheumatic diseases.
At issue is the immune system’s ability to take out the trash — to get rid of cells that don’t have long to live. “Just like in mice, in humans, if you don’t clear the dying cells, then that predisposes you to lupus,” said Lata Mukundan, a Stanford University School of Medicine researcher and co-author of a study published online Oct. 18 in the journal Nature Medicine.
“If you look at patients with lupus, they have an inability to clear those dead cells,” Mukundan said in a statement.
The study authors report that they gained insight into how immune-system cells detect which other cells are dying in order to dispose of them. They looked at human and mouse cells outside the body and in genetically engineered mice.
The researchers suspected that a molecule known as PPAR-delta was crucial to the process. “We wanted to know, if you took a mouse and only deleted PPAR-delta from its macrophages, is that sufficient to cause an autoimmune disease?” asked Dr. Ajay Chawla, assistant professor of endocrinology and co-author of the study, in a statement. “Apparently it is,” he said.
The researchers say currently existing drugs activate the molecule in question. Perhaps, they say, the drugs could treat lupus.
A new study finds no differences in blood mercury levels between children who are developing normally and those diagnosed with autism or autism spectrum disorders.
The findings, appearing online Oct. 19 in the journal Environmental Health Perspectives, may quell some of the debate surrounding mercury and autism.
The researchers did not, for instance, look at whether mercury might play a causal role in this group of developmental disorders.
“This is an excellent study that has addressed a very important question for many families about the role of mercury [in autism],” said Dr. Patricia Manning-Courtney, medical director of The Kelly O’Leary Center for Autism Spectrum Disorders at Cincinnati Children’s Hospital Medical Center. “It’s a very clear study [in] that no differences in mercury were seen. Is it going to put the questions to rest? I think no. It’s another important contribution to the large body of knowledge on this topic, but I think it will still be an area of great controversy.”
Previous studies have shown higher blood mercury levels in people with autism, but the results, along with the quality of the studies, have been inconsistent.
One of the biggest controversies claims that vaccines containing the preservative thimerosal, which contains mercury, might cause autism.
But thimerosal is no longer used routinely in children’s vaccines and, earlier this year, a U.S. court ruled that there is no scientific evidence that childhood vaccines such as the measles-mumps-rubella vaccine caused autism in children of parents seeking compensation from a federal fund.
The authors of this study wanted to fill one gap in the research: a lack of good evidence comparing mercury levels in children with autism and children without autism.
The authors looked at 452 children aged 2 to 5, who either had autism/autism spectrum disorder, developmental delays other than autism (such as Down syndrome), or who were developing normally.
Blood samples were taken from the children while mothers answered questions about different possible exposures to mercury, such as diet, dental amalgams, thimerosal-containing vaccines and even personal-care products such as earwax removal systems and nasal sprays.
First results showed that children with autism actually had much lower levels of mercury in their blood, but this was explained by the fact that these children ate less fish.
When the results were adjusted for this and other variables, mercury levels came out about the same between the autism group and the control group.
“Not only do we not see differences, but the values are pretty close to national averages,” said study author Irva Hertz-Picciotto, chief of environmental and occupational health and a faculty member at the MIND Institute at the University of California, Davis.
Overall, children with developmental delays other than autism had lower blood mercury concentrations.
Children who had mercury-based dental fillings who ground their teeth or chewed gum had blood concentrations of the metal. And those few children who had had a mercury-containing vaccine did not show elevations in their blood levels.
“The relationship between [mercury] intake to blood levels seems to follow the pattern that we expect and it’s well known that most of the mercury in the body does come from fish consumption,” Hertz-Picciotto said. “There really were very few children who had vaccines that would have or could have contained thimerosal.”
Most of the children in the study had received vaccines after thimerosal was removed from vaccines, she said.
Mercury only has a half-life in the circulating blood of a few months, Hertz-Picciotto said, so “clearly this does not tell us anything causal because all of the mercury represents exposure that had happened post-diagnosis.”
Sallie Bernard, executive director of SafeMinds (Sensible Action for Ending Mercury-Induced Neurological Disorders), expressed concern about confusing the findings with the interpretation of the findings.
“An interpretation says the study shows no link between mercury and autism, but that’s not what the paper is saying,” Bernard said. “It says they looked to see if [there] was higher exposure in kids with autism after they got their diagnosis. These are current exposures, not what might have happened at an earlier time point in pregnancy or in the first year of life, so you don’t know what affect that might have had.”
The study also does not go into whether certain children may be more susceptible to mercury’s effects, she said.
Vaccination at birth against hepatitis B virus greatly reduces the risk of liver cancer in young adulthood, new research suggests.
In a 20-year study that followed infants who were vaccinated against the liver disease in Taiwan beginning in 1984, when a universal vaccination program went into effect, Dr. Mei-Hwei Chang, of the Department of Pediatrics at the National Taiwan University Hospital in Taipei, and colleagues looked at young people who had developed liver cancer.
The researchers found that only a few people who had been vaccinated developed liver cancer, and there were possible explanations in most cases, such as insufficient doses of the vaccine.
The findings appear in the Sept. 16 online edition of the Journal of the National Cancer Institute.
“These data suggest that the effectiveness of the universal hepatitis B virus immunization program to prevent [liver cancer] has extended beyond childhood and into young adulthood over the past two decades,” the authors concluded.
In the United States, hepatitis B vaccination is recommended for all infants, older children and adolescents if they haven’t previously been vaccinated. Officials recommend that adults get the vaccination if they’re at risk for the disease.